# Kitty J. Jager

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kitty-j-jager/

## Facts

| Field | Value |
| --- | --- |
| Citations | 38,941 |
| Field | Dialysis and Renal Disease Management |
| h-index | 103 |
| i10-index | 407 |
| Last Known Institution | GGD Amsterdam |
| OpenAlex ID | https://openalex.org/A5046569845 |
| ORCID iD | 0000-0003-0444-8569 |
| Works | 670 |

## Researcher papers

Showing 12 of 25.

- [Chronic kidney disease](https://scholariq.org/papers/chronic-kidney-disease-3/)
- [Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease](https://scholariq.org/papers/sex-and-gender-disparities-in-the-epidemiology-and-outcomes-of-chronic-kidney/)
- [A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases](https://scholariq.org/papers/a-single-number-for-advocacy-and-communication-worldwide-more-than-850-million-2/)
- [An introduction to inverse probability of treatment weighting in observational research](https://scholariq.org/papers/an-introduction-to-inverse-probability-of-treatment-weighting-in-observational/)
- [External validation of prognostic models: what, why, how, when and where?](https://scholariq.org/papers/external-validation-of-prognostic-models-what-why-how-when-and-where/)
- [When do we need competing risks methods for survival analysis in nephrology?](https://scholariq.org/papers/when-do-we-need-competing-risks-methods-for-survival-analysis-in-nephrology/)
- [A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases](https://scholariq.org/papers/a-single-number-for-advocacy-and-communication-worldwide-more-than-850-million/)
- [CKD Prevalence Varies across the European General Population](https://scholariq.org/papers/ckd-prevalence-varies-across-the-european-general-population/)
- [Changes in the worldwide epidemiology of peritoneal dialysis](https://scholariq.org/papers/changes-in-the-worldwide-epidemiology-of-peritoneal-dialysis/)
- [Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe](https://scholariq.org/papers/results-from-the-era-edta-registry-indicate-a-high-mortality-due-to-covid-19-in/)
- [Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement](https://scholariq.org/papers/kidney-disease-improving-global-outcomes-guidelines-on-anaemia-management-in/)
- [The systemic nature of CKD](https://scholariq.org/papers/the-systemic-nature-of-ckd/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Organ Donation and Transplantation](https://scholariq.org/topics/organ-donation-and-transplantation/)

## Researcher university

- [GGD Amsterdam](https://scholariq.org/institutions/ggd-amsterdam/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.